Find Aminaftone manufacturers, exporters & distributors on PharmaCompass

Aminaftone

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 Europe

1 FDF Dossiers
1 Europe

GLOBAL SALES INFORMATION

1 Finished Drug Prices

globalSalesInformation
1 Finished Drug Prices

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Aminaftone, Aminaphthone, 14748-94-8, Aminaphtone, (1,4-dihydroxy-3-methylnaphthalen-2-yl) 4-aminobenzoate, 03jlx11pe9

Molecular Formula

C₁₈H₁₅NO₄

Molecular Weight

309.3 g/mol

InChI Key

YLMPBJUYFTWHKJ-UHFFFAOYSA-N

FDA UNII

03JLX11PE9

Aminaftone has been investigated for the treatment of Cockett Syndrome, May-Thurner Syndrome, and Iliac Vein Obstruction.

1 2D Structure

Aminaftone

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(1,4-dihydroxy-3-methylnaphthalen-2-yl) 4-aminobenzoate

2.1.2 InChI

InChI=1S/C18H15NO4/c1-10-15(20)13-4-2-3-5-14(13)16(21)17(10)23-18(22)11-6-8-12(19)9-7-11/h2-9,20-21H,19H2,1H3

2.1.3 InChI Key

YLMPBJUYFTWHKJ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=C(C2=CC=CC=C2C(=C1OC(=O)C3=CC=C(C=C3)N)O)O

2.2 Other Identifiers

2.2.1 UNII

03JLX11PE9

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Aminaftone

2. Aminaphthone

3. Capilarema

4. Capillarema

2.3.2 Depositor-Supplied Synonyms

1. Aminaftone

2. Aminaphthone

3. 14748-94-8

4. Aminaphtone

5. (1,4-dihydroxy-3-methylnaphthalen-2-yl) 4-aminobenzoate

6. 03jlx11pe9

7. Capilarema

8. Unii-03jlx11pe9

9. Capillarema

10. Menatriol

11. Capillarema (tn)

12. Einecs 238-809-8

13. Aminonaphthone

14. Aminaphthone [mart.]

15. Aminaphtone [who-dd]

16. Schembl12157532

17. Dtxsid00163725

18. Chebi:135317

19. Zinc5419379

20. Cs-6667

21. Db13039

22. Hy-19890

23. D07566

24. 3-methyl-1,2,4-naphthalenetriol-2-(4-aminobenzoate)

25. Q17620495

26. 1,2,4-naphthalenetriol, 3-methyl-, 2-(4-aminobenzoate)

27. 1,2,4-naphthalenetriol, 3-methyl-, 2-(p-aminobenzoate)

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₁₅NO₄
Molecular Weight	309.3 g/mol
XLogP3	3.6
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	3
Exact Mass	309.10010796 g/mol
Monoisotopic Mass	309.10010796 g/mol
Topological Polar Surface Area	92.8 Å²
Heavy Atom Count	23
Formal Charge	0
Complexity	421
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Hemostatics

Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)

FDF Dossiers